Active: new fund Jun 2026 Verified 4 Nov 2026
Banyan Bioinnovations
Boston investment firm powered by Locust Walk that forms clinical-stage drug development companies around assets sourced in the US, China and Japan.
- Type
- VC firm
- Location
- Boston, Massachusetts, United States
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $102M Banyan BioInnovations Capital Fund I (Form D amount sold, 2026)
- Latest fund or filing
- 3 Jun 2026
- Website
- www.banyan-bio.com
Fund filings (SEC Form D)
- Latest fund on file
- Banyan BioInnovations Capital Fund I
- Filed
- 3 Jun 2026 (new notice)
- Fund size
- $102M (amount sold)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Banyan Bioinnovations, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2136553/000213655326000001/
- adviserinfo.sec.gov/firm/summary/342873
- www.banyan-bio.com/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 10 lists
Biotech investors in Massachusetts (37)Healthtech investors in Massachusetts (58)Venture capital firms in Massachusetts (185)Emerging VC managers in the US (274)Biotech venture capital firms in the US (297)Biotech investors (484)Healthtech venture capital firms in the US (709)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Venture capital firms in the US (2,975)